Read more

July 21, 2020
6 min read
Save

Patient sex, race may impact decision-making for heart transplant, VAD allocation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In a survey of cardiac clinicians, researchers found that neither sex nor race of a patient predicted allocation of HF therapies, although bias was observed in the form of harsher judgment of women overall, particularly for Black women.

Khadijah Breathett

“As illustrated in this study, the current allocation process for advanced HF therapies (heart transplants and ventricular assist devices [VAD]) is subjective and at risk for bias,” Khadijah Breathett, MD, MS, assistant professor of medicine in the division of cardiology at the University of Arizona in Tucson, advanced heart failure and transplant cardiologist at Banner – University Medical Center in Tucson, told Healio. “In this study of health care professionals who make decisions regarding advanced therapies across the U.S., patient race and gender influenced the decision-making process. Although health care professionals were randomized to patients with identical clinical and social histories, social support assessments were biased against women, particularly African American women; however, the final recommendations did not differ by race and gender.”

Woman Patient Clinic
Source: Adobe Stock.

For this study, published in JAMA Network Open, researchers interviewed 46 U.S. clinicians (52% women; 43% from underrepresented groups) at an international heart transplantation conference in April 2019. Clinicians were shown clinical vignettes of Black and white men and women, all with similar HF profiles and histories, and discussed the decision-making process using the think-aloud technique. Clinicians were then surveyed on their final judgments for allocation of HF therapies.

Researchers noted five prevalent themes during the think-aloud interviewing process.

Five themes

First, the clinical vignettes of women were critiqued harshly for appearance, age, hair and facial expression.

“When I see her, I don’t think of her as totally friendly, I see someone who’s a little unkempt to some extent, and yet she’s probably fine and normal. That was my immediate reaction of not wanting the photo. Because I’m now making a decision about whether she is capable of taking care of herself or a machine based on her hair. Maybe there’s value there, but that’s not how we do it. And so, I was upset to see the photos. So anyway, that’s my feeling,” a white woman participant said about the white woman vignette.

Second, the Black man was perceived as being severely ill compared with participants in the other vignettes, according to the study.

“His risk of death in the next few months is very high. Again, still can’t decide his eligibility, but it means it may be indicated in an urgent setting for transplantation down the road,” a white man participant said about the Black man vignette.

Third, participants expressed high concern for the prior care of the Black woman compared with the white woman, researchers reported.

"It’s a shame that this lady was only diagnosed 2 years ago. I mean I get angry about that. I mean particularly being a [minority] provider, I see that many patients that are referred to me regardless of their race tend to be referred late from a heart failure standpoint. I find that my minority patients, particularly my African American patients, are referred even later. ... Many times it’s because their symptoms were going unrecognized by the people that were taking care of them ... or their symptoms weren’t believed. ... They tell me many stories and I’m hoping that this isn’t the case for her but unfortunately if you see it enough times ... it starts to dishearten you” a minority man participant said about the Black woman vignette.

Fourth, the clinicians expressed concern for social support for women and perceived children as liabilities for Black women, especially.

“I’m just worried about the fact that she’s taking care of little kids. She does have a spouse who will be her caregiver and so she does have support but I mean thus far nothing is a red flag, it’s just concern that those 2 kids need to be taken care of but she’s in the hospital,” a minority man participant said about the Black woman vignette.

Fifth, in the interview and the supplemental survey, the final recommendations for treatment were similar for both the Black woman and white woman vignettes:

“It’s just really challenging. I mean, you meet a person and they’re underinsured. They have a family, they’re a regular person, right? It’s easier when someone doesn’t have anyone; they’re divorced or they’ve never had kids and … they failed completely on the social side, but she’s got enough soft things that will make it challenging, and in our program, we would say, ‘We’ll take a chance on her for a VAD but not for a heart,” a white man participant said of a patient vignette of a white woman.

  • heart transplantation (mean Likert score rating, 7.53 vs. 6.53; P = .56);
  • bridge-to-transplant VAD (8.11 vs. 7.78; P = .79);
  • destination therapy (7 vs. 7.48; P > .99); and
  • no therapies (1.4 vs. 1.43; P >. 99).

Recommendations for therapies

Recommendations for VAD were more prevalent for the Black man vignette compared with the other vignettes (eg, bridge-to-transplant VAD, 8.21 for the Black man vs. 7.7 for the white man).

PAGE BREAK

Additionally, clinician support for advanced therapies was greater for the Black woman vignette compared with the others (eg, no therapy, 1.4 for Black woman vs. 1.96 for white man).

“In the U.S., women receive less than a quarter of advanced therapies and racial/ethnic minorities receive less than one-third,” Breathett said in an interview. “Given the need for appropriate social support prior to allocating advanced therapies, this study elucidates mechanisms for race and gender inequities in advanced HF therapy (ie, delays in care and denial of advanced therapies). In order to achieve health equity, advanced therapy centers should consider initiating steps to reduce bias and increase objectivity in the allocation process. The next phase of my clinical research aims to address these barriers to equity.”

Understanding biases, decreasing disparities

Social determinants of health play a key role in the assessment of candidates before placement on a waiting listing for a transplantation and should be taken into account to develop an active framework to minimize health disparities in cardiovascular health,” Bessie A. Young, MD, MPH, professor in the division of nephrology, section head of the VA Puget Sound Health Care System and associate chair for diversity and inclusion at the University of Washington, wrote in a related editorial. “Expanding access to care has increased the availability of heart transplantation for African American patients with Medicaid insurance, findings that were not uniform for patients from other minority groups. Understanding biases that may contribute to the allocation process are important and will allow for the standardization of that process, improvement in access to advanced heart failure therapies for women and patients from minority groups, and development of interventions aimed at decreasing health disparities in the assessment process.”

Reference:

Editor’s Note: This article was updated on July 24, 2020 with new descriptions of the clinical vignettes as requested by Dr. Breathett.